An investor consortium led by BlackRock (NYSE:BLK) has agreed to acquire a majority stake in Hong Kong-based CK Hutchison’s global port assets, including key docks on both sides of the Panama Canal. The $22.8 billion transaction hands control of these critical ports to U.S. and Swiss investors, aligning with the White House’s push to reduce Chinese influence in strategic locations.
The deal includes 43 ports across 23 countries but excludes CK Hutchison’s assets in China. The consortium, which includes BlackRock, Global Infrastructure Partners, and Terminal Investment, will take an 80% interest in Hutchison Ports, securing a 90% stake in Panama Ports Company, which operates the Balboa and Cristobal ports.
This move follows U.S. President Donald Trump’s vow to assert American influence over the canal, a critical trade route where over 75% of traffic is linked to the U.S. Trump previously expressed concerns over Chinese firms’ presence in Panama, and the sale is being viewed as a major geopolitical win for Washington.
U.S. Secretary of State Marco Rubio, a vocal critic of China’s influence in Latin America, had urged Panama to distance itself from Beijing. His recent visit coincided with Panama’s decision to exit China’s Belt and Road Initiative. The Panamanian government is also auditing CK Hutchison’s concession agreements amid legal challenges regarding its operations.
BlackRock, the world’s largest asset manager, has briefed the White House and congressional leaders on the acquisition, which marks its biggest infrastructure investment to date. The consortium has entered an exclusive 145-day negotiation period to finalize the agreement.
This acquisition reinforces U.S. economic and strategic interests in Latin America while positioning BlackRock for long-term infrastructure dominance.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
Instagram Outage Disrupts Thousands of U.S. Users
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



